Navigation Links
The wonders of wine
Date:9/17/2009

nd tested have convinced the team that the ProVino product could be attractive to health-conscious consumers. They also offer a good use for red wine by-products, the disposal of which is now subject to tighter European regulation and which cannot just be dumped on land. Every year in Germany alone, there are about 120,000 hectolitres of wine by-products, enough to produce 12,000 tonnes of dried red wine powder.

ProVino's partners are now talking to companies interested in the powder for specific products. If enough firms want a powder to be produced for a product, Spectral may even consider creating a new company just to manufacture the powder. Another alternative for the commercialisation of the powder is that a manufacturer buys the ProVino method.

One of the ProVino products has already been tested on consumers on a small scale, thanks to EUREKA, which encouraged the partners to market their results at the Innovation Days exhibition held in June in Lisbon. PROVINO set up a stand and gave out a yoghurt drink containing the red-wine powder. "That was really invaluable because we were forced to talk about the product, not just to companies, but also to ordinary people. We were forced to ask do they like the product?" says Randel.

The response of those who tasted the yoghurt drink was positive, even from those who were initially reluctant to try it, she says. "Some Spanish and Italian guys told us they liked red wine but that it seemed weird to have it in a powder. When they tried it we convinced them."


'/>"/>

Contact: Dr. Gabriele Randele
randel@spectralservice.de
49-223-696-9470
EUREKA
Source:Eurekalert

Page: 1 2 3


Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... A commonly inherited gene deletion can increase t...ne marrow transplantation, an international team o...nline issue of Nature Genetics . When the gene, c...but present in the recipient,s, transplants have a...ct known as graft-versus-host disease, in which im...
(Date:11/22/2009)... Scientists at the Brain Research Centre, a partne...y of Medicine and Vancouver Coastal Health Researc...the mechanism by which brain cells die following a...t damage. The results of the study were recently p...g a stroke, many brain cells continue to die even ...
(Date:11/20/2009)... In a research report published in the November 20...netics.org ), scientists show how a family of gene...ACS genes) are responsible for production of ethyl...pment, and this information lays the foundation fo...ts disease resistant, able to survive and thrive i...
Breaking Biology News(10 mins):Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 1NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 2NAMI Issues 26quot 3BStigma Alert 26quot 3B Over Inaccurate and Offensive Halloween Costumes Attractions 60294 3The Top 10 Business Mistakes Made By Physician Practices 60292 1The Top 10 Business Mistakes Made By Physician Practices 60292 2Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2 2009 60290 1Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2 2009 60290 2
... has grown new muscle complete with its own networ...d the new muscle in a living mouse. The accomplish...to a report in the June 19 issue of Nature Biotech...f the Technion-Israel Institute of Technology, alo...e of Technology, grew the muscle from scratch by s...
...hat allows the final step in the completion of new...niversity of California, San Diego (UCSD) School o...to a new way to halt tumor growth by cutting off t...Judith Varner, Ph.D., Associate Professor of Medic...oores UCSD Cancer Center, made the surprising disc...
... three molecules –?from a search of 58,000 compoun...lzheimer,s disease. , Each of the three molecules ...opelessly tangled in the brains of patients with A...development of drugs for the disease. , Ken Kosik...te at the University of California, Santa Barbara,...
Other Biology News:New complete muscle grown in the lab 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Scientists discover that three molecules may be developed into new Alzheimer's drugs 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 3
(Date:11/18/2009)...nstitute of Standards and Technology (NIST) has de... for detecting and measuring elusive hazards such ...lage in food or pesticides distributed in soil by ...ive than conventional techniques for detecting tra...molecules, having distinct electrically positive a...
(Date:11/18/2009)... Nov. 18 Sangamo BioScie...ata from the University of Pennsylvania investigat...c finger nuclease (ZFN) based product, SB-728-T, f...closed on the internet. ,, Data were presented ...nia School of Medicine from a single subject treat...
(Date:11/18/2009).... 18 Reportlinker.com announces th...s catalogue. ,, Biotechnology Reagents - A Gl...tlinker.com/p0164375/Biotechnology-Reagents---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...emical compounds used in a range of biotech relate...
(Date:11/18/2009)...tly reduces key cardiac enzymes at multiple time p...rican Heart Association 2009 Scientific Sessions ,...rapeutics Inc., a biotechnology company pioneering...apeutics derived from pathogens, today reported re...T-111 (Serp-1), an anti-inflammatory protein deriv...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...AAP Operating Earnings Up 6% - Non-GAAP Di...LTO, Calif., Jan. 23 Varian, Inc.,(NasdaqGS: VARI...37.4,million, representing an increase of 8.9% ove...of fiscal year 2007. The increase was broad-based,...ence and industrial,(which includes environmental,...
... and capabilities to facilitate ...toclave technology provides environmentally ...e addition of the autoclave, one of approximately ...e country capable of treating all types ...pportunity for additional revenue streams - Exp...
...r Molecular,Medicine (CMM) today announced the hir...o support the expansion of the laboratory,s clinic... Jin He, who previously served as a senior lab tec... of Clinical Science, has been hired as,a scientis...medicine from,Anhui Medical University, located in...
Other Biology Technology:Varian, Inc. Reports First Quarter 2008 Results 2Varian, Inc. Reports First Quarter 2008 Results 3Varian, Inc. Reports First Quarter 2008 Results 4Varian, Inc. Reports First Quarter 2008 Results 5Varian, Inc. Reports First Quarter 2008 Results 6Varian, Inc. Reports First Quarter 2008 Results 7Varian, Inc. Reports First Quarter 2008 Results 8Varian, Inc. Reports First Quarter 2008 Results 9Varian, Inc. Reports First Quarter 2008 Results 10Varian, Inc. Reports First Quarter 2008 Results 11Varian, Inc. Reports First Quarter 2008 Results 12Varian, Inc. Reports First Quarter 2008 Results 13Varian, Inc. Reports First Quarter 2008 Results 14Varian, Inc. Reports First Quarter 2008 Results 15Varian, Inc. Reports First Quarter 2008 Results 16Varian, Inc. Reports First Quarter 2008 Results 17Varian, Inc. Reports First Quarter 2008 Results 18Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 2Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 3Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 4The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent 2
... Rotator, variable speed, timer, SB3, Fully a...l timer, Choice of tube holders to hold a number...he SB3 is ideal for aerating cultures, keeping bio...ng applications., The rotator can be used in ...
Horseradish Peroxidase (HRP) Conjugation Kit For labeling Antigens/Antibodies (Reaction Time 2 hr) from Alpha Diagnostic International Inc
... The DNA Engine Opticon 2 real-time PCR detection ... excitation (470-505 nm) and two photomultiplier t...). The Opticon 2 system is built on an DNA Engine ...feature. This item includes the thermal cycler, 96...
... The Mini-PROTEAN II multiscreen apparatus is used...he apparatus can screen up to 40 different antibod...rips. The apparatus includes a base plate, 2 separ...one or two 8 x 7 cm membranes, and gaskets and cla...
Biology Products: